GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
pharmaceutical manufacturers in Europe:
sales of 36.20 billion Euro [US$40.95 billion]
of which 83%
(35.02 billion Euro [US$39.61 billion]
of which 48%
was Pharmaceuticals & Biological Products), and
based in Switzerland
(49.16 billion Swiss Francs [US$48.86 billion]
of which 66%
was Innovative Medicines).
During the year ended December of 2017, sales at
GlaxoSmithKline plc were £30.19 billion (US$39.25 billion).
increase of 8.2%
versus 2016, when the company's sales were £27.89 billion.
This was the third consecutive year of growth at GlaxoSmithKline plc.
Sales of Vaccines saw an increase
12.4% in 2017, from
£4.59 billion to £5.16 billion.